Option Care Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
October 27, 2022 at 12:37 pm
Share
Option Care Health, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 1,020.92 million compared to USD 891.94 million a year ago. Net income was USD 38.82 million compared to USD 35.48 million a year ago. Basic earnings per share from continuing operations was USD 0.21 compared to USD 0.2 a year ago. Diluted earnings per share from continuing operations was USD 0.21 compared to USD 0.2 a year ago.
For the nine months, sales was USD 2,917.52 million compared to USD 2,511.45 million a year ago. Net income was USD 103.03 million compared to USD 64.43 million a year ago. Basic earnings per share from continuing operations was USD 0.57 compared to USD 0.36 a year ago. Diluted earnings per share from continuing operations was USD 0.57 compared to USD 0.36 a year ago.
Option Care Health, Inc. is an independent provider of home and alternate site infusion services. The Companyâs infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of 93 full-service pharmacies and 84 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, heart failure, chronic inflammatory disorders, immunoglobulin infusion, bleeding disorders infusion, nutrition support infusion, neurological disorders, and others. The Companyâs home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patientâs condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.